Tumores neuroendocrinos: impacto de LANREÓTIDA en la supervivencia de la enfermedad estable y progresiva - page 20

STABLE DISEASE REALLY MEANS

0% OF TUMOR GROWTH RATE ??

Caplin M, et al.

ASCO

2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,10,11,12,13,14,15,16,17,18,19 21,22,23,24,25,26